Albemarle Corporation

Valuation Analysis

About the Company

Albemarle Corporation en bref

Albemarle Corporation (ALB) is currently trading at 139,72 € with a market capitalization of 16,5 Md €. The 52-week range spans from 48,73 € to 192,66 €; the current price is 27.5% below the yearly high. Year-over-year revenue growth stands at +32.7%.

💰 Dividende

Albemarle Corporation pays an annual dividend of 1,41 € per share, representing a yield of 1.01%. The payout ratio stands at 57.97%.

📊 Avis des analystes

22 analystes évaluent Albemarle Corporation (ALB) au consensus : Acheter. L'objectif de cours moyen est de 187,00 €, soit un potentiel de +33.85% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 72,60 € à 230,15 €.

Albemarle Corporation : la thèse d'investissement en détail

Albemarle Corporation (ALB) operates in the Basic Materials — specifically Specialty Chemicals — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

Top-line momentum is unusually strong with revenue expanding 32.7% year-over-year, a pace that puts the company well above the market average and signals genuine demand traction rather than mere cyclical tailwind. Wall Street consensus sits at Buy with an average price target implying roughly 33.85% upside from current levels — analyst sentiment is firmly constructive.

Le scénario baissier

Net margins remain negative, meaning every euro of revenue is still producing losses — the path to profitability is the central question for shareholders.

Valorisation en contexte

The PEG ratio at 1.02 sits in the reasonable zone — the price tag is roughly aligned with the company's growth profile, neither punishing nor euphoric.

À surveiller

• The analyst consensus price target implies 33.85% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Thèse d'investissement : forces et faiblesses

Aperçu technique

Price shows short-term weakness (below 50d MA) but is still in a longer-term uptrend (above 200d MA).

Profil de risque

The data points to market-like volatility.

Trading Data

💵 Dividend Info

Related Stocks in the Same Sector

Where can I buy Albemarle Corporation?

Compare top-rated brokers — low fees, trusted providers, fully regulated.